CURX Curanex Pharmaceuticals Inc

Fundamentals / CIK 0002025942 / USD

Curanex Pharmaceuticals Inc reported $3.10M in total assets and a net loss of $12.33M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CURX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

2 fiscal years (2024 to 2025), reported in USD.

$0$0$0-$3.95MFY 2024 Net Income: -$362K2024FY 2025 Net Income: -$4.23M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31
Research & Development $2.99M --
Total Operating Expenses $4.24M $365K
Operating Income -$4.24M -$365K
Interest Expense $8.5K --
Net Income -$4.23M -$362K
Basic EPS -$3.40 -$0.60
Diluted EPS -$3.40 -$0.60
Basic Shares Outstanding 1.3M 663.0K
Diluted Shares Outstanding 1.3M 663.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $1.95M $2.59M $2.26M -- $677K -- -- --
Total Operating Expenses $2.83M $3.33M $3.18M $3.09M $951K $58K $137K --
Operating Income -$2.83M -$3.33M -$3.18M -$3.09M -$951K -$58K -$137K --
Interest Expense -- -- -- $0 $4.1K $3.1K $1.4K --
Net Income -$2.82M -$3.29M -$3.15M -$3.07M -$954K -$60K -$138K -$146K
Basic EPS -$1.86 -$2.40 -$2.20 -- -$0.75 $0.00 -$0.20 --
Diluted EPS -$1.86 -$2.40 -$2.20 -- -$0.75 $0.00 -$0.20 --
Basic Shares Outstanding 1.5M 1.4M 1.4M -- 1.3M 1.2M 1.2M --
Diluted Shares Outstanding 1.5M 1.4M 1.4M -- 1.3M 1.2M 1.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $5.00M $149K
Cash & Short-Term Investments $5.00M $149K
Other Current Assets -- $368K
Total Current Assets $11.23M $518K
Total Non-Current Assets $353K $0
Total Assets $11.58M $518K
Accounts Payable $2.4K $5.0K
Total Current Liabilities $137K $15K
Total Non-Current Liabilities $224K $0
Total Liabilities $361K $15K
Total Debt (incl. Leases) $347K --
Common Stock $142 $2.4K
Retained Earnings -$4.85M -$622K
Total Stockholders' Equity $11.22M $503K
Total Equity $11.22M $503K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2024-12-31
Cash & Cash Equivalents $1.58M $2.94M $4.00M $5.00M $5.80M $109K $149K
Cash & Short-Term Investments $1.58M $2.94M $4.00M $5.00M $5.80M $109K $149K
Other Current Assets -- -- -- -- -- $596K $368K
Total Current Assets $2.56M $4.79M $8.09M $11.23M $14.42M $711K $518K
Total Non-Current Assets $541K $281K $318K $353K $60K $76K $0
Total Assets $3.10M $5.07M $8.41M $11.58M $14.48M $787K $518K
Accounts Payable -- $154 $8.4K $2.4K $114K $269 $5.0K
Total Current Liabilities $143K $104K $129K $137K $186K $76K $15K
Total Non-Current Liabilities $409K $182K $204K $224K $0 $406K $0
Total Liabilities $552K $286K $333K $361K $186K $482K $15K
Total Debt (incl. Leases) $542K $276K $311K $347K $61K $76K --
Common Stock $157 $2.8K $2.8K $142 $2.8K $2.4K $2.4K
Retained Earnings -$14.10M -$11.29M -$8.00M -$4.85M -$1.77M -$820K -$622K
Total Stockholders' Equity $2.55M $4.79M $8.08M $11.22M $14.29M $305K $503K
Total Equity $2.55M $4.79M $8.08M $11.22M $14.29M $305K $503K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31
Net Income -$4.23M -$362K
Change in Payables -$2.6K $5.0K
Operating Cash Flow -$10.48M -$556K
Common Stock Issued -- $630K
Financing Cash Flow $15.31M $630K
Net Change in Cash $4.82M $75K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.82M -$3.29M -$3.15M -$3.07M -$954K -$60K -$138K -$146K
Stock-Based Compensation $154K $0 $9.8K -- -- -- -- --
Change in Payables -$154 -$8.2K $6.0K -$112K $114K -$126K $121K --
Operating Cash Flow -$1.36M -$1.08M -$955K -$857K -$9.19M -$290K -$150K --
Financing Cash Flow -- -- -- $0 $14.91M $200K $200K --
Net Change in Cash -$1.36M -$1.08M -$955K -$857K $5.72M -$90K $50K --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31
Return on Equity (ROE) -37.7% -71.8%
Return on Assets (ROA) -36.5% -69.8%
Current Ratio 81.93x 35.54x
Quick Ratio 36.49x 10.22x
Debt to Equity 0.03x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -484.4% -218.7% -89.6% -37.7% -9.1% -142.4% -- -71.8%
Return on Assets (ROA) -398.1% -206.3% -86.0% -36.5% -9.0% -55.3% -- -69.8%
Current Ratio 17.84x 45.95x 62.87x 81.93x 77.53x 9.37x -- 35.54x
Quick Ratio 11.02x 28.17x 31.07x 36.49x 31.19x 1.43x -- 10.22x
Debt to Equity 0.21x 0.06x 0.04x 0.03x 0.00x 0.25x -- --
Source: SEC EDGAR CompanyFacts (CIK 0002025942) · from March 31, 2024 Data through September 30, 2026 · synced Nov 21, 2026, 05:07 UTC · Open in terminal